{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-25-005749","form_type":"8-K","ticker":"ZOMDF","cik":"0001684144","company_name":"Zomedica Corp.","filed_at":"2025-05-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.333401+00:00","generated_at":"2026-05-21T05:17:43.324826+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Zomedica Q1 revenue $6.5M (+4% YoY), net loss $63.8M on $55.8M impairment","bullets":["Revenue $6.5M (+4% YoY); gross margin 68% vs 66% in Q1 2024.","Net loss $63.8M includes $55.8M non-cash impairment from share price decline.","Adjusted EBITDA loss $5.7M vs $5.3M in Q1 2024; cash & securities $64.6M.","Consumables revenue up 13% to $4.5M; Diagnostics down 25% to $0.6M.","Shares outstanding 979.9M; liquidity down from $71.4M at Dec 31, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-25-005749","json":"https://secwatch.observer/filing/0001654954-25-005749.json","markdown":"https://secwatch.observer/filing/0001654954-25-005749.md","text":"https://secwatch.observer/filing/0001654954-25-005749.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1684144/000165495425005749/0001654954-25-005749-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1684144/000165495425005749/zom_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T05:17:43.324826+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}